secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRATA Skin Sciences, Inc. (SSKN)
CIK:        0001051514
Form:       8-K
Filed at:   2025-03-20T23:59:59+00:00
Accession:  0001140361-25-009587
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STRATA Skin Sciences highlights clinical study showing excimer laser superiority over excimer light
--------------------------------------------------------------------------------

- Published study from Nippon Medical School shows excimer laser penetrates deeper into hair follicles and activates more melanocyte stem cells than excimer light.
- Laser delivers 1,000 mJ/cm² in one second vs 20 seconds for excimer light, with less DNA damage and epidermal side effects.
- Over 100 XTRAC excimer lasers placed in Japan since 2019, including 24 in 2024; global installed base exceeds 2,800 units.
- CEO states study validates XTRAC's technological advantages for treating vitiligo, psoriasis, alopecia areata, and atopic dermatitis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1051514/000114036125009587/0001140361-25-009587-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1051514/000114036125009587/ef20045839_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-009587

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer